发明名称 |
Method of using adenoviral vectors with increased persistence in vivo |
摘要 |
The invention provides a method of expressing an exogenous nucleic acid in a mammal. The method comprises slowly releasing into the bloodstream a dose of replication-deficient or conditionally-replicating adenoviral vector having reduced ability to transduce mesothelial cells and hepatocytes. The normalized average bloodstream concentration of the adenovirus over 24 hours post-administration is at least about 1%. Alternatively, the normalized average bloodstream concentration over 24 hours post-administration is at least about 5-fold greater than the normalized average bloodstream concentration for an equivalent dose of a wild-type adenoviral vector. A method of destroying tumor cells in a mammal also is provided.
|
申请公布号 |
US2004167088(A1) |
申请公布日期 |
2004.08.26 |
申请号 |
US20030374271 |
申请日期 |
2003.02.25 |
申请人 |
GENVEC, INC. |
发明人 |
WICKHAM THOMAS J.;AKIYAMA MASAKI |
分类号 |
A61K48/00;C12N15/861;(IPC1-7):A61K48/00 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|